نتایج جستجو برای: ژن نوکلئوفسمین npm1

تعداد نتایج: 16927  

2017
Kiyohiro Ando Melissa J Parsons Richa B Shah Chloé I Charendoff Sheré L Paris Peter H Liu Sara R Fassio Brittany A Rohrman Ruth Thompson Andrew Oberst Samuel Sidi Lisa Bouchier-Hayes

The PIDDosome (PIDD-RAIDD-caspase-2 complex) is considered to be the primary signaling platform for caspase-2 activation in response to genotoxic stress. Yet studies of PIDD-deficient mice show that caspase-2 activation can proceed in the absence of PIDD. Here we show that DNA damage induces the assembly of at least two distinct activation platforms for caspase-2: a cytoplasmic platform that is...

Journal: :Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2015
Rosemary E Gale Katarina Lamb Christopher Allen Dima El-Sharkawi Cassandra Stowe Sarah Jenkinson Steven Tinsley Glenda Dickson Alan K Burnett Robert K Hills David C Linch

PURPOSE To evaluate the impact of DNMT3A mutations on outcome in younger patients with cytogenetic intermediate-risk acute myeloid leukemia. PATIENTS AND METHODS Diagnostic samples from 914 patients (97% < 60 years old) were screened for mutations in DNMT3A exons 13 to 23. Clinical outcome was evaluated according to presence or absence of a mutation and stratified according to type of mutatio...

Journal: :Haematologica 2008
Francesco Lo-Coco Antonio Cuneo Fabrizio Pane Daniela Cilloni Daniela Diverio Marco Mancini Nicoletta Testoni Antonella Bardi Barbara Izzo Niccolò Bolli Roberta La Starza Paola Fazi Simona Iacobelli Alfonso Piciocchi Marco Vignetti Sergio Amadori Franco Mandelli Pier Giuseppe Pelicci Cristina Mecucci Brunangelo Falini Giuseppe Saglio

BACKGROUND Recent advances in genetic characterization of acute myeloid leukemia indicate that combined cytogenetic and molecular analyses provide better definition of prognostic groups. The aim of this study was to verify this prospectively in a large group of patients. DESIGN AND METHODS Genetic characterization was prospectively carried out in 397 patients with acute myeloid leukemia (medi...

2012
Isabella Faraoni Serena Laterza Davide Ardiri Claudia Ciardi Francesco Fazi Francesco Lo-Coco

BACKGROUND MicroRNA have a central role in normal haematopoiesis and are deregulated in acute myeloid leukaemia (AML). The purpose of the study was to investigate by qRT-PCR the expression of miRNAs involved in myeloid differentiation (miR-424, miR-155, miR-223, miR-17-5p) in 48 patients with cytogenetically normal AML well characterized for NPM1 and/or FLT3 mutations. Three types of normalizat...

Journal: :Archives of medical science : AMS 2016
Dorota Koczkodaj Szymon Zmorzyński Małgorzata Michalak-Wojnowska Ewa Wąsik-Szczepanek Agata A Filip

INTRODUCTION Acute myeloid leukemia (AML) is a genetically heterogeneous disease at both the cytogenetic and molecular levels. In AML cells many chromosomal aberrations are observed, some of them being characteristic of a particular subtype of patients, and others being less significant. Besides chromosomal abnormalities, the leukemic cells can have a variety of mutations involving individual g...

Journal: :Cancer research 2012
Tomoya Fukawa Masaya Ono Taisuke Matsuo Hisanori Uehara Tsuneharu Miki Yusuke Nakamura Hiro-omi Kanayama Toyomasa Katagiri

Studies of renal cell carcinoma (RCC) have led to the development of new molecular-targeted drugs but its oncogenic origins remain poorly understood. Here, we report the identification and critical roles in renal carcinogenesis for DDX31, a novel nucleolar protein upregulated in the vast majority of human RCC. Immunohistochemical overexpression of DDX31 was an independent prognostic factor for ...

Journal: :Molecular and cellular biology 2014
Nithya Raman Arnab Nayak Stefan Muller

Ribosome biogenesis is a multistep cellular pathway that involves more than 200 regulatory components to ultimately generate translation-competent 80S ribosomes. The initial steps of this process, particularly rRNA processing, take place in the nucleolus, while later stages occur in the nucleoplasm and cytoplasm. One critical factor of 28S rRNA maturation is the SUMO-isopeptidase SENP3. SENP3 t...

Journal: :Einstein 2011
Elvira Deolinda Rodrigues Pereira Velloso Carlos Henrique Ares Silveira da Motta Juliana Braga Furtado Nydia Strachman Bacal Paulo Augusto Achucarro Silveira Cynthia Bachir Moyses Roberta Sitnik João Renato Rebello Pinho

OBJECTIVE To study the frequency of mutations that may lead to a good or bad prognosis, as well as their relation with the karyotype and immunophenotype in patients with acute myeloid leukemia. METHODS Thirty samples of patients with acute myeloid leukemia were studied, in which FLT3-ITD, FLT3-TKD and NPM1 mutations were investigated. All samples were submitted to immunophenotyping and 25 to ...

2016
Glenda J. Dickson Sophia Bustraan Robert K. Hills Akbar Ali Anthony H. Goldstone Alan K. Burnett David C. Linch Rosemary E. Gale

Older adult patients (≥60 years) with acute myeloid leukaemia (AML) are generally considered to be poor-risk and there is limited information available regarding risk stratification based on molecular characterization in this age group, particularly for the double-mutant CEBPA (CEBPA(DM) ) genotype. To investigate whether a molecular favourable-risk genotype can be identified, we investigated C...

Journal: :Blood 2011
Claire L Green Catherine M Evans Lu Zhao Robert K Hills Alan K Burnett David C Linch Rosemary E Gale

We have investigated the prognostic significance of isocitrate dehydrogenase 2 (IDH2) mutations in 1473 younger adult acute myeloid leukemia patients treated in 2 United Kingdom Medical Research Council trials. An IDH2 mutation was present in 148 cases (10%), 80% at R140 and 20% at R172. Patient characteristics and outcome differed markedly between the 2 mutations. IDH2(R140) significantly corr...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید